Lethbridge, Alta. : University of Lethbridge, Dept. of Biological Sciences
Cannabinol inhibits proliferation and induces cell cycle arrest and apoptosis in glioblastoma, hepatocellular carcinoma and breast cancer cells
Abstract
dc:description.abstractCannabis sativa is an agriculturally and medicinally important plant with many pharmaceutical properties. Cancer is a deadly disease; it is estimated that it will cause over 80 thousand deaths in 2019 in Canada. Although numerous studies have demonstrated that cannabinoids have anti-tumorous properties in various cancers, the anti-malignant activities of cannabinol (CBN) on carcinogenesis and underlying mechanisms remain largely unknown. In this study, we provide evidence that CBN inhibits proliferation of A172, HB8065 and HCC1806 cells in a dose- and time-dependent manner. CBN regulates expression of cannabinoid receptors, CB2, GPR55 and GPR18 in different cell lines, while reducing levels of phosphorylated ERK1/2 in HCC1806 and phosphorylated AKT in A172 and HB8065 cells. We find that CBN induces apoptosis through downregulation of p21 and p27 and a G1 or S-phase cell cycle arrest through a dose-dependent downregulation of cyclin E1, CDK1 and CDK2. These data support the medicinal potential of CBN in anti-cancer therapy.
Degree
thesis:*- Level thesis:degree_level
- Masters
- Grantor dc:publisher
- Lethbridge, Alta. : University of Lethbridge, Dept. of Biological Sciences
- Year dc:date.issued
- 2020
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Zhong, Nuanying
- University of Lethbridge. Faculty of Arts and Science
- Advisor dc:contributor.supervisor
-
- Kovalchuk, Igor
Subjects
dc:subject × 6Rights
- Language dc:language.iso
- en_US
Identifiers
dc:identifier.*- Handle dc:identifier.uri
- https://hdl.handle.net/10133/5697